GeoVax Labs, Inc. (GOVX): EBITDA
-$21.57M
Year ended 2025-12-31
-$20.47M
Trailing 12 months to 2026-06-30
| Period ended | EBITDA | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$21.57M | n/m | 2026-04-15, From 2025-01-01 |
| 2024-12-31 | -$25.05M | n/m | 2026-04-15, From 2024-01-01 |
| 2023-12-31 | -$26.67M | n/m | 2025-03-27, From 2023-01-01 |
| 2022-12-31 | -$13.97M | n/m | 2024-02-29, From 2022-01-01 |
| 2021-12-31 | -$18.71M | n/m | 2023-03-23, From 2021-01-01 |
| 2020-12-31 | -$2.80M | n/m | 2022-03-09, From 2020-01-01 |
| 2019-12-31 | -$2.36M | n/m | 2021-03-23, From 2019-01-01 |
| 2018-12-31 | -$2.54M | n/m | 2020-03-24, From 2018-01-01 |
| 2017-12-31 | -$2.15M | n/m | 2019-03-26, From 2017-01-01 |
| 2016-12-31 | -$3.24M | n/m | 2019-03-26, From 2016-01-01 |
| 2015-12-31 | -$2.67M | n/m | 2018-03-23, From 2015-01-01 |
| 2014-12-31 | -$2.67M | n/m | 2017-03-24, From 2014-01-01 |
| 2013-12-31 | -$2.21M | n/m | 2016-03-16, From 2013-01-01 |
| 2012-12-31 | -$2.05M | n/m | 2015-03-20, From 2012-01-01 |
| 2011-12-31 | -$2.24M | n/m | 2014-03-14, From 2011-01-01 |
| 2010-12-31 | -$2.65M | n/m | 2013-03-18, From 2010-01-01 |
| 2009-12-31 | -$3.23M | n/a | 2012-03-30, From 2009-01-01 |
EBITDA at similar companies
| Company | Year ended | EBITDA | Change YoY |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | 2025-12-31 | -$21.57M | n/m |
| Upstream Bio, Inc. (UPB) | 2025-12-31 | -$160.17M | n/m |
| TherapeuticsMD, Inc. (TXMD) | 2025-12-31 | -$4.01M | n/m |
| Lipocine Inc. (LPCN) | 2025-12-31 | -$10.31M | n/m |
| Bio Essence Corp (BIOE) | 2025-12-31 | $900.2K | n/m |
| Camp4 Therapeutics Corp (CAMP) | 2025-12-31 | -$50.92M | n/m |
| Rani Therapeutics Holdings, Inc. (RANI) | 2025-12-31 | -$37.41M | n/m |
| China Pharma Holdings, Inc. (CPHI) | 2025-12-31 | -$1.74M | n/m |
| NRX Pharmaceuticals, Inc. (NRXP) | 2025-12-31 | -$16.15M | n/m |
Compare GOVX, UPB, TXMD, LPCN side by side · Screen every company in Pharmaceutical Preparations ↗